Results for tag: "Relamorelin"

Relamorelin is a peptide agonist of the ghrelin receptor, used to treat endocrine and metabolic disorders. It is a synthetic version of ghrelin, a hormone that regulates appetite and energy balance. Relamorelin is used to treat short bowel syndrome (SBS) and other conditions associated with intestinal failure. It works by stimulating the release of growth hormone, which helps to improve nutrient absorption and reduce the risk of malnutrition. It also helps to reduce the risk of complications associated with SBS, such as dehydration and electrolyte imbalances. Relamorelin is administered as an injection, and is available in both brand name and generic forms. It is approved for use in adults and children over the age of two. Common side effects include nausea, headache, and injection site reactions. Companies in the Relamorelin market include Novo Nordisk, Takeda Pharmaceuticals, and Shire Pharmaceuticals. Show Less Read more